A new WHYY report highlights persistent gaps in access to opioid addiction medications in Philadelphia. Addiction medicine specialist Maggie Lowenstein led a study where researchers posed as case managers to assess treatment programs, finding that while appointment availability has improved, barriers to immediate access for lifesaving medication like buprenorphine remain. Lowenstein stresses that delays in care put lives at risk and calls for programs to align with the latest evidence-based guidelines.
Opioid Treatment Access in Philly Still Uneven
